Type 1 5α-reductase may be required for estrous cycle changes in affective behaviors of female mice

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 376-380

  Koonce, Carolyn J ^a   Walf, Alicia A ^a   Frye, Cheryl A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Allopregnanolone; Anxiety; Cortex; Elevated plus maze; Hippocampus; Open field

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CORTICOSTERONE; ESTRADIOL; PROGESTERONE; STEROID 5ALPHA REDUCTASE 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD LEVEL; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ESTRUS CYCLE; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; KNOCKOUT MOUSE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN METABOLISM; TISSUE DISTRIBUTION; WILD TYPE;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 5-ALPHA-DIHYDROPROGESTERONE; ANIMALS; ANXIETY; CEREBRAL CORTEX; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROUS CYCLE; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROGESTERONE;

EID: 81355160322     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.028     Document Type: Article

References (57)

1. Gray P., Cooney J. Stress-induced responses and open-field behavior in estrous and nonestrous mice. Physiol Behav 1982, 29:287-292.
2. Walf A.A., Koonce C., Manley K., Frye C.A. Proestrous compared to diestrous wildtype, but not estrogen receptor β knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 2009, 196:254-260.
3. Li X., Bertics P.J., Karavolas H.J. Regional distribution of cytosolic and particulate 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol 1997, 60:311-318.
4. Pinna G., Agis-Balboa R.C., Pibiri F., Nelson M., Guidotti A., Costa E. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res 2008, 33:1990-2007.
5. Corpéchot C., Collins B.E., Carey M.P., Tsouros A., Robel P., Fry J.P. Brain neurosteroids during the mouse oestrous cycle. Brain Res 1997, 766:276-280.
6. Frye C.A., Vongher J.M. Progesterone and 3α,5α-THP enhance sexual receptivity in mice. Behav Neurosci 2001, 115:1118-1128.
7. Russell D.W., Wilson J.D. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994, 63:25-61.
8. Normington K., Russell D.W. Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem 1992, 267:19548-19554.
9. Beckley E.H., Finn D.A. Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol Biochem Behav 2007, 87:412-419.
10. Smith S.S., Ruderman Y., Frye C., Homanics G., Yuan M. Steroid withdrawal in the mouse results in anxiogenic effects of 3α,5β-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 2006, 186:323-333.
11. Mahendroo M.S., Cala K.M., Russell D.W. 5α-reduced androgens play a key role in murine parturition. Mol Endocrinol 1996, 10:380-392.
12. Mahendroo M.S., Cala K.M., Landrum D.P., Russell D.W. Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess. Mol Endocrinol 1997, 11:917-927.
13. Frye C.A., Walf A.A., Rhodes M.E., Harney J.P. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase. Brain Res 2004, 116-124.
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 2nd ed.
15. Walf A.A., Koonce C.J., Frye C.A. Estradiol or diarylproionitrile decreases anxiety-like behavior of wild-type, but nor estrogen receptor β knockout, mice. Behav Neurosci 2008, 122:974-981.
16. Frye C.A., Sumida K., Dudek B.C., Harney J.P., Lydon J.P., O'Malley B.W., Pfaff D.W., Rhodes M.E. Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology 2006, 186:312-322.
17. Frye C.A., Koonce C.J., Walf A.A. Mnemonic effects of progesterone to mice require formation of 3α,5α-THP. Neuroreport 2010, 21:590-595.
18. Maguire J.L., Stell B.M., Rafizadeh M., Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 2005, 8:797-804.
19. Palanza P., Gioiosa L., Parmigiani S. Social stress in mice: gender differences and effects of estrous cycle and social dominance. Physiol Behav 2001, 73:411-420.
20. Agís-Balboa R.C., Pinna G., Pibiri F., Kadriu B., Costa E., Guidotti A. Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. PNAS 2007, 104:18736-18741.
21. Pibiri F., Nelson M., Guidotti A., Costa E., Pinna G. Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. PNAS 2008, 105:5567-5572.
22. Frye C.A., Rhodes M.E. Progestin concentrations are increased following paced mating in midbrain, hippocampus, diencephalon, and cortex of rats in behavioral estrus, but only in midbrain of diestrous rats. Neuroendocrinology 2006, 83:336-347.
23. Akwa Y., Purdy R.H., Koob G.F., Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 1999, 106:119-125.
24. Crain C., Paris J.J., Frye C.A. 3α,5α-THP has actions in the hippocampus to modulate exploratory, anti-anxiety, and socio-sexual behavior in female rats. Abstr Annu Meeting Soc Neurosci 2007.
25. Engin E., Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 2007, 18:461-470.
26. Frye C.A., Walf A.A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behav Neurosci 2004, 118:306-313.
27. Frye C.A., Walf A.A. Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alternation, object recognition, but not placement, water maze, and contextual and cued conditioned fear tasks. Neurobiol Learn Mem 2008, 90:171-177.
28. Frye C.A., Walf A.A. Progesterone enhances performance of aged mice in cortical or hippocampal tasks. Neurosci Lett 2008, 437:116-120.
29. Orr P.T., Lewis M.C., Frick K.M. Dorsal hippocampal progesterone infusions enhance object recognition in young female mice. Pharmacol Biochem Behav 2009, 93:177-182.
30. Büttner D. Climbing on the cage lid, a regular component of locomotor activity in the mouse. J Exp Anim Sci 1991, 34:165-169.
31. Galeeva A., Tuohimaa P., Shaliapina V.G. Role of sex steroids in development of anxiety in female mice. Ross Fiziol Zh Im I M Sechenova 2001, 87:1680-1687.
32. Imwalle D.B., Gustafsson J.A., Rissman E.F. Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005, 84:157-163.
33. Morgan M.A., Pfaff D.W. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res 2002, 132:85-93.
34. Tomihara K., Soga T., Nomura M., Korach K.S., Gustafsson J.A., Pfaff D.W., Ogawa S. Effect of ER-β gene disruption on estrogenic regulation of anxiety in female mice. Physiol Behav 2009, 96:300-306.
35. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
36. Cheng Y.J., Karavolas H.J. Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medial basal hypothalamus and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology 1973, 93:1157-1162.
37. Micevych P., Sinchak K. Estradiol regulation of progesterone synthesis in the brain. Mol Cell Endocrinol 2008, 13:44-50.
38. Frye C.A., Rhodes M.E. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol Biochem Behav 2005, 81:907-916.
39. Vongher J.M., Frye C.A. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav 1999, 64:777-785.
40. Frye C.A., Walf A.A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002, 41:306-315.
41. Rhodes M.E., Frye C.A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci 2001, 1:287-296.
42. Walf A.A., Sumida K., Frye C.A. Inhibiting 5α-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats. Psychopharmacology 2006, 186:302-311.
43. Chikahisa S., Sano A., Kitaoka K., Miyamoto K., Sei H. Anxiolytic effect of music depends on ovarian steroid in female mice. Behav Brain Res 2007, 179:50-59.
44. Frye C.A., Rhodes M.E., Walf A., Harney J. Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type mice but not those deficient in type I 5α-reductase. Epilepsia 2002, 43(Suppl 5):14-17.
45. Edinger K.L., Frye C.A. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus. Behav Neurosci 2004, 118:1352-1364.
46. Edinger K.L., Frye C.A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus. Psychoneuroendocrinology 2005, 30:418-430.
47. Frye C.A., Edinger K.L. Testosterone's metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacol Biochem Behav 2004, 78:473-481.
48. Frye C.A., Koonce C.J., Edinger K.L., Osborne D.M., Walf A.A. Androgens with activity at estrogen receptor β have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 2008, 54:726-734.
49. Frye C.A., Rhodes M.E., Walf A.A., Harney J.P. Testosterone reduces pentylenetetrazole-induced ictal activity of wildtype mice but not those deficient in type I 5α-reductase. Brain Res 2001, 918:182-186.
50. Frye C.A., Rhodes M.E., Walf A., Harney J.P. Testosterone enhances aggression of wild-type mice but not those deficient in type I 5α-reductase. Brain Res 2002, 948:165-170.
51. Seeman M.V. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997, 154:1641-1647.
52. Brambilla F., Biggio G., Pisu M.G., Bellodi L., Perna G., Bogdanovich-Djukic V., Purdy R.H., Serra M. Neurosteroid secretion in panic disorder. Psychiatry Res 2003, 118:107-116.
53. Rasmusson A.M., Pinna G., Paliwal P., Weisman D., Gottschalk C., Charney D., Krystal J., Guidotti A. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry 2006, 60:704-713.
54. Romeo E., Ströhle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998, 155:910-913.
55. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998, 95:3239-3244.
56. Carter R.N., Paterson J.M., Tworowska U., Stenvers D.J., Mullins J.J., Seckl J.R., Holmes M.C. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11β-HSD1 is strain-dependent. J Neuroendocrinol 2009, 21:879-887.
57. Yehuda R., Bierer L.M., Sarapas C., Makotkine I., Andrew R., Seckl J.R. Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology 2009, 34:1304-1313.